VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 424 filers reported holding VANECK VECTORS ETF TR in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $576 | -3.0% | 21,396 | +8.6% | 0.08% | +1.3% |
| Q2 2023 | $594 | -6.6% | 19,708 | +0.4% | 0.08% | -8.3% |
| Q1 2023 | $636 | +18.0% | 19,638 | +4.6% | 0.08% | +9.1% |
| Q4 2022 | $539 | -99.9% | 18,773 | -2.1% | 0.08% | +13.2% |
| Q3 2022 | $463,000 | -15.4% | 19,179 | -3.8% | 0.07% | -11.7% |
| Q2 2022 | $547,000 | +27250.0% | 19,944 | +66380.0% | 0.08% | – |
| Q2 2020 | $2,000 | -98.6% | 30 | -99.5% | 0.00% | -100.0% |
| Q2 2019 | $144,000 | +10.8% | 5,615 | -8.4% | 0.03% | -6.1% |
| Q4 2018 | $130,000 | +17.1% | 6,130 | +2.5% | 0.03% | +37.5% |
| Q3 2018 | $111,000 | -52.4% | 5,982 | -42.7% | 0.02% | -53.8% |
| Q2 2018 | $233,000 | +30.9% | 10,432 | +29.1% | 0.05% | +100.0% |
| Q1 2018 | $178,000 | – | 8,079 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |